Wet (Neovascular / Exudative) Macular Degeneration Market Share, Trends, H2 2016

Hexa Reports
Market Research Reports and Insightful Company Profiles

Wet (Neovascular / Exudative) Macular Degeneration
Market Share, Size, Trends, Symtoms, Treatment, Pipeline
Review, H2 2016

Global Markets Direct's, 'Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2
2015', provides an overview of the Wet (Neovascular / Exudative) Macular Degeneration's therapeutic
pipeline.
This report provides comprehensive information on the therapeutic development for Wet (Neovascular
/ Exudative) Macular Degeneration, complete with comparative analysis at various stages, therapeutics
assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule
type, along with latest updates, and featured news and press releases. It also reviews key players
involved in the therapeutic development for Wet (Neovascular / Exudative) Macular Degeneration and
special features on late-stage and discontinued projects.
Browse Detail Report With TOC @ http://www.hexareports.com/report/wet-neovascular-exudativemacular-degeneration-pipeline-review-h2-2015/details
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is built using data and information sourced from Global
Markets Direct's proprietary databases, Company/University websites, SEC filings, investor

Hexa Reports
Market Research Reports and Insightful Company Profiles
presentations and featured press releases from company/university sites and industry-specific third
party sources, put together by Global Markets Direct's team.
Drug profiles/records featured in the report undergoes periodic updation following a stringent set of
processes that ensures that all the profiles are updated with the latest set of information. Additionally,
processes including live news & deals tracking, browser based alert-box and clinical trials registries
tracking ensure that the most recent developments are...